Yale University

Jenny Machida Joins CD&R as Managing Director of Portfolio Talent

Retrieved on: 
Monday, March 4, 2024
Watson Wyatt Worldwide, Dubilier, Katzenbach Partners, Booz, Investment, MBA, IMB, Chairperson, Clayton, Dubilier & Rice, CD&R, University, Partner, Yale University, PwC, Public, Willis Towers Watson, Management

NEW YORK, March 4, 2024 /PRNewswire/ -- Clayton, Dubilier & Rice ("CD&R" or the "Firm") today announced the appointment of Jenny Machida as Managing Director of Portfolio Talent, a newly created position to bring additional capability to support our investment teams' focus on talent across the investment life cycle.

Key Points: 
  • NEW YORK, March 4, 2024 /PRNewswire/ -- Clayton, Dubilier & Rice ("CD&R" or the "Firm") today announced the appointment of Jenny Machida as Managing Director of Portfolio Talent, a newly created position to bring additional capability to support our investment teams' focus on talent across the investment life cycle.
  • Ms. Machida has more than 25 years of experience in direct investing, management consulting and building businesses.
  • Prior to that, Ms. Machida was a Partner and Managing Director at private equity firm IMB Partners, where she played a lead role in talent due diligence, post-close strategic planning and in partnering with management teams to execute value creation initiatives.
  • Prior to IMB, Ms. Machida was co-founder, Chief Business Officer and Board Chair at a start-up medical diagnostic technology company called Sevident.

GenNx360 Expands with New Director of Business Development, Jordan Buxton - Punch

Retrieved on: 
Wednesday, February 28, 2024
Acquisition, Investment, Wells Fargo, Business development, Venture capital, St. Paul's School, Yale University, Science, Partnership

NEW YORK, Feb. 28, 2024 /PRNewswire/ -- GenNx360 Capital Partners ("GenNx360"), a New York-based private equity buyout firm investing in middle market industrial and business services companies, announced today the addition of Jordan Buxton - Punch as Director of Business Development.

Key Points: 
  • NEW YORK, Feb. 28, 2024 /PRNewswire/ -- GenNx360 Capital Partners ("GenNx360"), a New York-based private equity buyout firm investing in middle market industrial and business services companies, announced today the addition of Jordan Buxton - Punch as Director of Business Development.
  • Jordan will manage all aspects of the origination process for both platform and bolt-on acquisitions, including sourcing, relationship management and partnership identification.
  • Prior to joining GenNx360, Jordan served as Director of Business Development for Live Chair, Inc., a Venture Capital-funded start up.
  • Prior to Live Chair, Jordan was Senior Vice President, Investments at Nightingale Partners LLC, a private investment vehicle and Opportunity Zone Fund.

L-Nutra Unveils Groundbreaking Research on Fasting Mimicking Diets (FMDs) and Reduced Biological Age Score

Retrieved on: 
Wednesday, February 28, 2024
Nature, The, NHANES, Ageing, Health, Food, Harvard University, Joslin Diabetes Center, University of Southern California, FMD, Longevity, Facial muscles, University, Fasting, Yale University, Nature Communications, Life, Research, Medicine, Dietary supplement

LOS ANGELES, Feb. 28, 2024 /PRNewswire/ -- L-Nutra Inc., a leading nutrition technology company developing evidence-based Nutrition for Longevity and Nutrition as Medicine programs, is excited to announce the release of a groundbreaking longevity and healthy aging study published in Nature Communications, a prestigious Nature portfolio journal. The data suggests that following three consecutive monthly rounds of ProLon® 5-Day may decrease a person's biological age score by 2.5 years. 

Key Points: 
  • The data suggests that following three consecutive monthly rounds of ProLon® 5-Day may decrease a person's biological age score by 2.5 years.
  • L-Nutra's flagship product, ProLon® 5-day Fasting Mimicking Diet (FMD), the first patented precision nutrition program shown to support cellular rejuvenation and metabolic reset effects of prolonged fasting, was provided to participants.
  • This research further solidifies L-Nutra's commitment to advancing scientific understanding and practical applications of nutrition for living longer and healthier.
  • This study marks a significant step forward in understanding the effect of fasting-mimicking diets (FMD) in cellular rejuvenation, metabolic reset, and supporting healthy living.

VALISURE ANNOUNCES NEW VENTURE PARTNERS AND EXPANSION OF LEADERSHIP TEAM

Retrieved on: 
Wednesday, February 28, 2024
Engineering, CVS Health, Teva Pharmaceuticals, MinuteClinic, Research, Chemistry, Walgreens, Investment, University of Cambridge, Health, Growth, Overalls, Harvard University, Government, Mathematics, Ion semiconductor sequencing, Safety, Health care, University, Yale University, CVS, Thermo Fisher Scientific, Economics, Robotics, Medicaid, Social impact, Biology, Meetup, Expansion, DNA, Public, Management

NEW HAVEN, Conn., Feb. 28, 2024 /PRNewswire/ -- Valisure, a healthcare industry pioneer for independent quality assurance in pharmaceutical drugs, has recently received substantial investments from leading healthcare venture capital firms to accelerate Valisure's rapid growth and impact. Concurrently, the company is pleased to announce key leadership developments, including appointing a highly experienced healthcare leader as CEO and additional expansion of its executive team.

Key Points: 
  • Concurrently, the company is pleased to announce key leadership developments, including appointing a highly experienced healthcare leader as CEO and additional expansion of its executive team.
  • Valisure has gained global recognition for its commitment to ensuring the safety and quality of medications through its highly impactful, independent testing.
  • "I look forward to collaborating with the talented team and enabling Valisure to expand its work with the industry to strategically address these issues."
  • Likewise, Wolfgang Hinz, Ph.D., has assumed a pivotal leadership position as the Chief Scientific Officer of Valisure.

The 6th Edition of The World Happiness Summit® comes to London Next Month Elevating Human Wellbeing: A Paradigm Shift in Focus

Retrieved on: 
Wednesday, February 28, 2024
Workplace, AI, Education, Queen Elizabeth Hall, Surgeon, Southbank Centre, Government, Loneliness, Labour Party (UK), Organic, London School of Economics, Organization, Summit, Policy, Yale University, Heart, Society, Unilever, Harvard Business School, Management

"We are championing the idea that wellbeing should be the ultimate goal in education, business, and government."

Key Points: 
  • "We are championing the idea that wellbeing should be the ultimate goal in education, business, and government."
  • The by-invitation World Wellbeing Policy Forum, a pro bono initiative of WOHASU in collaboration with the World Wellbeing Movement , will discuss the economics and policy of wellbeing and the price of unhappiness.
  • It will also have the live European launch of the World Happiness Report 2024, which will rank youth happiness for the first time in the report's 11-year history.
  • The expert speakers will provide a fresh perspective on the interconnectedness of human wellbeing, business success, environmental sustainability, and societal progress.

Equitable Breakthroughs in Medicine Development Reaches Next Phase Driving Diversity in Clinical Trials in Georgia, South Carolina, Tennessee, and Texas

Retrieved on: 
Tuesday, February 27, 2024
Senior, Research, Morehouse School of Medicine, Medical school, Education, MHS, Vanderbilt University Medical Center, University, History, Internal medicine, Texas Southern University, Principal, Professor, Health informatics, MBA, FACP, FACC, Partnership, Informatics, RCMI, Drug discovery, Yale School of Medicine, Yale University, MPH, Clinical trial, Health equity, Trust, Face, Innovation, Public health, Dean (education), Patient, Yale school, Science, Nursing

NEW HAVEN, Conn., Feb. 26, 2024 /PRNewswire/ -- Equitable Breakthroughs in Medicine Development (EQBMED), led by Yale School of Medicine, Morehouse School of Medicine, the Research Centers in Minority Institutions Coordinating Center (RCMI) at Morehouse School of Medicine, and Vanderbilt University Medical Center, is a partnership bringing clinical trial sites closer to the community to further equity and access for diverse populations. Today, EQBMED announced the selection of the first four Learning Phase sites, moving the needle closer to a scalable and sustainable clinical trial model in historically underserved communities. The partnerships include:

Key Points: 
  • Today, EQBMED announced the selection of the first four Learning Phase sites, moving the needle closer to a scalable and sustainable clinical trial model in historically underserved communities.
  • The program works to increase awareness of clinical trials, address misinformation and historical mistrust, while ensuring the trial is easily accessible.
  • The EQBMED partnership meets sites where they are, building on their strengths and capabilities to become sustainable within the clinical trial ecosystem.
  • "EQBMED is making real progress towards equitable access to clinical trials and enhancing these sites with needed resources."

Aprio Wealth Management Releases 2024 Wealth Management Economic Outlook

Retrieved on: 
Tuesday, February 27, 2024
Electric Power Research Institute, Investment, Growth, Federal Reserve, Yale University, GDP, Depression, Fed, Morgan Stanley, Quantitative easing, Electricity, LLP, Uncertainty, Aprio, LLP, Unemployment, Environment

ATLANTA, Feb. 27, 2024 /PRNewswire-PRWeb/ -- Aprio Wealth Management, a subsidiary of Aprio, LLP, the fastest-growing business advisory and accounting firm in the U.S., has released its 2024 Wealth Management Economic Outlook, highlighting investment trends, insights and takeaways for investors to watch in 2024, as well as long-range economic and investment tailwinds.

Key Points: 
  • Outlook predicts diminished likelihood for a recession, continued global economic normalization and cautionary investment strategies
    ATLANTA, Feb. 27, 2024 /PRNewswire-PRWeb/ -- Aprio Wealth Management , a subsidiary of Aprio, LLP , the fastest-growing business advisory and accounting firm in the U.S. , has released its 2024 Wealth Management Economic Outlook , highlighting investment trends, insights and takeaways for investors to watch in 2024, as well as long-range economic and investment tailwinds.
  • "Our goal is to provide clients with the clarity and confidence they need to make informed investment and business decisions," said Simeon Wallis, Chief Investment Officer, Aprio Wealth Management .
  • "This year's Wealth Management Economic Outlook underscores that the current traditional signals in the economic cycle have been less predictive than ever, making it even more critical that investors and executives take an integrated and coordinated approach to their wealth management and business strategies."
  • To explore these wealth management and economic predictions in depth and prepare your 2024 investment and business strategies, visit https://www.wealth.aprio.com/ and download your copy of the 2024 Wealth Management Economic Outlook.

Elevage Medical Technologies Continues Expansion of Investment Team and Board

Retrieved on: 
Tuesday, February 27, 2024
Frazier Healthcare Partners, Teleflex, Investment, Biological engineering, Mechanical, MIT, Invention, Growth, National academy, MBA, Senior advisor, Revelation, Biomedicine, Mechanical engineering, Patent, Bard (company), Needham & Company, Yale University, Acclarent, Medtronic, Columbia University, American Institute, Management

AUSTIN, Texas, Feb. 27, 2024 /PRNewswire/ -- Elevage Medical Technologies ("Elevage"), a portfolio company of Patient Square Capital, dedicated to supporting growth-stage medical device and medical technology companies, today announced key additions to the investment team and board. Vice-Presidents Suchira Sharma and Peter Tortora join the Elevage investment team, along with Dr. Josh Makower, a Senior Advisor to Patient Square and Elevage, who will also join the Elevage Board of Directors.

Key Points: 
  • hires –
    AUSTIN, Texas, Feb. 27, 2024 /PRNewswire/ -- Elevage Medical Technologies ("Elevage"), a portfolio company of Patient Square Capital , dedicated to supporting growth-stage medical device and medical technology companies, today announced key additions to the investment team and board.
  • Vice-Presidents Suchira Sharma and Peter Tortora join the Elevage investment team, along with Dr. Josh Makower, a Senior Advisor to Patient Square and Elevage, who will also join the Elevage Board of Directors.
  • Dr. Evan Melrose, CEO of Elevage Medical, said, "We are thrilled with these three key additions to the Elevage team.
  • Dr. Makower is also the Founder & Executive Chairman of ExploraMed, a medical device incubator that has created eleven companies since 1995.

Equitable Breakthroughs in Medicine Development Reaches Next Phase Driving Diversity in Clinical Trials in Georgia, South Carolina, Tennessee, and Texas

Retrieved on: 
Monday, February 26, 2024
Senior, Research, Morehouse School of Medicine, Medical school, Education, MHS, Vanderbilt University Medical Center, University, History, Internal medicine, Texas Southern University, Principal, Professor, Health informatics, MBA, FACP, FACC, Partnership, Informatics, RCMI, Drug discovery, Yale School of Medicine, Yale University, MPH, Clinical trial, Health equity, Trust, Face, Innovation, Public health, Dean (education), Patient, Yale school, Science, Nursing

NEW HAVEN, Conn., Feb. 26, 2024 /PRNewswire/ -- Equitable Breakthroughs in Medicine Development (EQBMED), led by Yale School of Medicine, Morehouse School of Medicine, the Research Centers in Minority Institutions Coordinating Center (RCMI) at Morehouse School of Medicine, and Vanderbilt University Medical Center, is a partnership bringing clinical trial sites closer to the community to further equity and access for diverse populations. Today, EQBMED announced the selection of the first four Learning Phase sites, moving the needle closer to a scalable and sustainable clinical trial model in historically underserved communities. The partnerships include:

Key Points: 
  • Today, EQBMED announced the selection of the first four Learning Phase sites, moving the needle closer to a scalable and sustainable clinical trial model in historically underserved communities.
  • The program works to increase awareness of clinical trials, address misinformation and historical mistrust, while ensuring the trial is easily accessible.
  • The EQBMED partnership meets sites where they are, building on their strengths and capabilities to become sustainable within the clinical trial ecosystem.
  • "EQBMED is making real progress towards equitable access to clinical trials and enhancing these sites with needed resources."

Loretta Martinez Named Inaugural Senior Vice President and General Counsel of LMU

Retrieved on: 
Monday, February 26, 2024
Catholic Church, City, CUNY, Multimedia, Education, Loyola Marymount University, Harvard Law School, University, Private sector, Colorado College, Yale University, Knowledge, LMU, City University, Management

LOS ANGELES, Feb. 26, 2024 /PRNewswire/ -- Loretta P. Martinez, J.D., an accomplished attorney with more than 25 years of experience, primarily as general counsel in public and private higher education institutions, will be the inaugural senior vice president and general counsel of Loyola Marymount University.

Key Points: 
  • LOS ANGELES, Feb. 26, 2024 /PRNewswire/ -- Loretta P. Martinez, J.D., an accomplished attorney with more than 25 years of experience, primarily as general counsel in public and private higher education institutions, will be the inaugural senior vice president and general counsel of Loyola Marymount University.
  • "I am excited to bring my background as a higher education general counsel to a university with LMU's national reputation and impact," Martinez said.
  • At Colorado College, Martinez served as general counsel and board secretary for more than eight years.
  • Martinez earned her Juris Doctorate at Harvard Law School and her Bachelor of Arts in political science from Yale University.